Navigation Links
QRxPharma Releases Successful Phase 3 Study Results for 'Dual Opioid' Pain Therapy
Date:5/5/2008

Q8003IR Met Primary Endpoints; Demonstrated Strong Reduction of Pain Intensity

SYDNEY, Australia and BEDMINSTER, N.J., May 5

/PRNewswire-FirstCall/ -- QRxPharma Limited (ASX: QRX), a clinical-stage specialty pharmaceutical company focused on the development and commercialisation of therapies for pain and central nervous system (CNS) disorders, announced today initial Phase 3 efficacy results for Q8003IR, an immediate release dual-opioid product intended for the acute management of moderate to severe pain.

"Initial Phase 3 efficacy data demonstrated statistically significant analgesic activity at all doses tested and reinforces the potential clinical benefit and commercial value of QRxPharma's lead dual-opioid product," said Dr. John Holaday, Managing Director and Chief Executive Officer, QRxPharma. "We are pleased with this study outcome and believe that it demonstrates that the Company remains on target to complete clinical testing for Q8003IR, submit a New Drug Application (NDA) in 2009 and achieve its goal of product launch in 2010."

The double-blind, placebo-controlled study was designed to compare the efficacy and safety of four different dosage regimens of Q8003IR, a fixed ratio morphine/oxycodone combination. 256 patients with moderate to severe pain following surgery (bunionectomy) completed the trial, and it was conducted at six US clinical research sites. The primary efficacy analysis compared the change in pain intensity scores over the 48 hr dosing period (SPID48) in patients receiving Q8003IR vs. placebo.

Among all patients receiving Q8003IR, approximately 50% reported good to excellent global improvement (vs. 13% for placebo) and demonstrated a strong dose-response effect (p<0.001) in reducing pain intensity scores [i.e. the sum of pain intensity difference over 48 hours relative to the first dose (SPID48)] and other measures of analgesic effect. Per treatment group, median doses received every 4 hours
'/>"/>

SOURCE QRxPharma
Copyright©2008 PR Newswire.
All rights reserved

0

GOOD

Page: 1 2 3

Related medicine technology :

1. QRxPharma Doses First Patients in Phase III Clinical Trial Program for its Dual Opioid Pain Therapy
2. Immunosyn Releases Wound Healing Photographs From the First Phase Proof of Concept Trial in Europe for Treatment of Diabetic Ulcers With Biopharmeceutical SF-1019
3. TCS Healthcare Technologies Releases Three New Clinical Care Programs Within ACUITY
4. Immunosyn Corporation Releases SF-1019 Study Results
5. Cardinal Health Releases New Tool to Combat MRSA Infections in Hospitals
6. AcroMetrix Releases New OptiQuant(R) HIV-1 Quantification Panel
7. CEL-SCI Corporation Releases Letter to Shareholders
8. Sarasotas Roskamp Institute Releases Study Defining a Mechanism for Development of Obesity and the Metabolic Syndrome, Forerunners of Type 2 Diabetes
9. Data Show Preoperative Assessment of Breast Cancer Patients Enables Early Diagnosis, Successful Treatment of Lymphedema
10. Novagali Pharma Successfully Enrolls First Patient in U.S. Phase I Clinical Study with CORTIJECT(R) for Diabetic Macular Edema
11. Nostrum Announces the Successful Completion of Early Proof-of-Concept Study for its Novel Clot Busting Therapeutic Protein

Post Your Comments:
*Name:
*Comment:
*Email:
(Date:11/23/2009)...CK,Mass.,Nov.23/PRNewswire-FirstCall/--BostonScien...teinthePiperJaffrayHealthCareConference,December1-...cerandSamLeno,ExecutiveVicePresidentandChiefFinanc...outtheCompanyonTuesday,December1st,beginningatappr...ussionwillbeavailabletoallinterestedpartiesatBosto...
(Date:11/23/2009)...TRICHMOND,Calif.,Nov.23/PRNewswire-FirstCall/--Tra...uncedthatitisscheduledtomeetwiththeU.S.FoodandDrug...pleteResponseLetterregardingtheNewDrugApplication(...gualtablet).Aspreviouslyannounced,theCompleteRespo...catedthattheFDAcouldnotapprovetheNDAinitspresentfo...
(Date:11/23/2009)...SANDOAKS,Calif.,Nov.23/PRNewswire-FirstCall/--Amge...inningforBestOverallPipelineandforBestNewDrugforNp... ,, TheBestOverallPipelineawardwaspresentedtoAm...dmarketpotentialofthecompany,spipeline,aswellasits...thejudges,Amgen,spipelineisnotableforitsfocusonunm...
Breaking Medicine Technology:Transcept Pharmaceuticals Scheduled to Meet With FDA to Discuss Intermezzo(R) Complete Response Letter 2Amgen Recognized for Best Pipeline and Best New Drug at Scrip Awards 2Amgen Recognized for Best Pipeline and Best New Drug at Scrip Awards 3Amgen Recognized for Best Pipeline and Best New Drug at Scrip Awards 4Amgen Recognized for Best Pipeline and Best New Drug at Scrip Awards 5Amgen Recognized for Best Pipeline and Best New Drug at Scrip Awards 6Video 3A CVS pharmacy Kicks Off 8th Annual ALS Fundraising Campaign in Stores Nationwide 48169 1Video 3A CVS pharmacy Kicks Off 8th Annual ALS Fundraising Campaign in Stores Nationwide 48169 2Video 3A CVS pharmacy Kicks Off 8th Annual ALS Fundraising Campaign in Stores Nationwide 48169 3Interleukin Genetics Launches Inherent Health Brand of Genetic Tests Offering Clear and Personalized Insights to Wellness 48165 1Interleukin Genetics Launches Inherent Health Brand of Genetic Tests Offering Clear and Personalized Insights to Wellness 48165 2Interleukin Genetics Launches Inherent Health Brand of Genetic Tests Offering Clear and Personalized Insights to Wellness 48165 3Interleukin Genetics Launches Inherent Health Brand of Genetic Tests Offering Clear and Personalized Insights to Wellness 48165 4Interleukin Genetics Launches Inherent Health Brand of Genetic Tests Offering Clear and Personalized Insights to Wellness 48165 5Cadient Group Brings Home the Gold and Two Bronze Aster Awards 12521 1Cadient Group Brings Home the Gold and Two Bronze Aster Awards 12521 2
...Participating in certain mental activities, like r...r in life, may delay or prevent memory loss, accor...ted at the American Academy of Neurology,s 61st An..., , The study involved 197 people between the age...diagnosed memory loss, and 1,124 people that age w...
...eb. 20 Adam B. Smith, D.O., FACOS, of Fort Worth ...ort Worth metroplex chosen by Allergan Medical for...Balloon (BIB) System to Assist in the Weight Manag...rmine the safety and effectiveness of BIB, an infl...nction with a behavior modification program compar...
Other Medicine Technology:Can Exercising Your Brain Prevent Memory Loss? 2Fort Worth Surgeon Chosen as Investigator in Clinical Trial for Weight-Loss Device 2
(Date:11/23/2009)... After suffering from women,s hair l...s growing back and she,s sharing her progress and ...her women through the release of her video diaries...ore and during her treatment. , ...hair loss sufferer Zsanett Siklosi has released t...
(Date:11/23/2009)...BORO,Pa.,Nov.23/PRNewswire-FirstCall/--InfoLogix,I...erprisemobilitysolutionsforthehealthcareandcommerc...residentofManagedServicesatSiemensHealthServices,h...areServices. ,, (Logo: http://www.newscom.com/c...sidentofStrategicHealthcareServicesforInfoLogix,Mr...
(Date:11/23/2009)...rters of cancer patients and survivors treated wit...that often become chronic conditions, hindering pa...entists at the University of Rochester Medical Cen...y experienced sleep troubles at nearly three times...as more prevalent in younger patients and those wi...
(Date:11/23/2009)... saw their odds drop by 63 percent with moderate-t...v. 23 (HealthDay News) -- Moderate-to-high intensi...y help reduce stroke risk in older men but not in ... almost 3,300 men and women, average age 69, in Ma...ring that time, there were 238 strokes among the p...
(Date:11/23/2009)...s up weaknesses of drug approval process in United.... 23 (HealthDay News) -- Problems with the popular...r heart attack, stroke and death, were known for y...he market in 2004, a new report says. , Contra... dangerous side effects were evident in 2000, a ye...
Breaking Medicine News(10 mins):Health News:Women's Hair Loss Treatment Results Captured on Video to Inspire Others 2Health News:Women's Hair Loss Treatment Results Captured on Video to Inspire Others 3Health News:Jim Way, Former Vice President at Siemens Health Services, Joins InfoLogix, Inc. as Vice President of Strategic Healthcare Services 2Health News:Jim Way, Former Vice President at Siemens Health Services, Joins InfoLogix, Inc. as Vice President of Strategic Healthcare Services 3Health News:Insomnia prevalent among cancer patients who receive chemotherapy 2Health News:Vigorous Exercise Cuts Stroke Risk for Men, Not Women 2Health News: Vioxx Problems Known Years Before Recall 2Health News: Vioxx Problems Known Years Before Recall 3Health News: Vioxx Problems Known Years Before Recall 4
...al etiology is a challenging problem for the prima...act localization of lesion to either small or larg...ts. In tropical countries, where most of the popul...th good sensitivity and specificity. Small bowel e...
...(Nasdaq: ABAX ), a medical products company manu...nounced today that Clint Severson, chairman and ch...; Company,s Eleventh Annual Growth,Stock Conferenc...axis develops, manufactures and markets portable b...
...st about possible outcomes, study finds , ...jority of families of critically ill patients want...s even if it is uncertain, a new study finds. , ...Medicine , points out a definite rift in this area...
...National Glaucoma,Awareness Month, Glaucoma Resear...versary with a benefit at the historic Palace Hote...nt serves as the showcase for recent advances in,G...ucoma if nothing is,done. "Early detection and tre...
...ugh uphill climb if he,s to tackle Obama,s health ...medical records (EMR) are seeing the writing on th...ectronic medical billing is part of their softwa...rty solution offered by MPMsoft. , , Netalytics, ...
...ns New Products and Expanded Services in 2009 , ...mber 29, 2008 – Fisher Vista, LLC has report...in 2008, boosted by significant growth of its core...ervices Group , established in 2006, helped fuel t...
Other Medicine News:Health News:A new screening test for chronic abdominal pain 2Health News:Family Needs to Know When Patient Survival Is Uncertain 2Health News:Electronic Medical Billing: Going Electronic with Health Care Billing. 2Health News:Fisher Vista, LLC Reports Seventh Consecutive Year of Revenue Growth and Profitability 2Health News:Fisher Vista, LLC Reports Seventh Consecutive Year of Revenue Growth and Profitability 3
Pectoralis Implants
...izes. Long-term implantable, soft medical grade si.... Each preformed block can be easily trimmed or mo...n patient., Carving Blocks are solid silicone and ...f surgical options for augmentation of tissue or b...
...ing extension of the IQmark Diagnostic Workstation...based PC to deliver unmatched speed, accuracy and ...download and seamlessly integrate test results int...e. The point-and-click functionality eliminates th...
...ransformation in less than an hour with the Obagi ...her superficial procedures, the Obagi Blue Peel pu...ur patients' particular skin needs, you determine ... peels and number of coats applied. A blue mixing ...
Medicine Products: